David is an experienced finance professional and chartered accountant, with over two decades of experience in the life sciences industry.

He has held CFO roles at numerous healthcare companies including Juvenescence, a life sciences company developing therapies to modify ageing and increase healthy human lifespan, Silence Therapeutics, a biotechnology company harnessing the body’s natural mechanism of RNA interference (RNAi) and, more recently, Sixfold Bioscience, a company focused on RNA delivery using AI/ML. Early in his career, he qualified as an accountant at PwC, transitioning to a variety of financial and internal audit roles at companies including Smith & Nephew.